Locations:

Research

June 3, 2019/Cancer/Research

New Renal Cancer Therapy Effective in Higher Risk Groups

Another option for immunotherapy

June 1, 2019/Cancer/Research

Optimal Total Dose of Cisplatin for High-Risk Oral Cavity Squamous Cell Carcinoma

It nearly doubles median disease-free survival

May 23, 2019/Cancer/Research

Antiestrogen with PI3K Inhibitor: The Next Dynamic Duo for ER+, HER2– Metastatic Breast Cancer

Will we see this major breakthrough in 2019?

February 26, 2019/Cancer/Research

Antibody Treatment Holds Promise for Patients with Relapsed or Refractory Light-Chain Amyloidosis

Daratumumab is effective and safe

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

February 7, 2019/Cancer/Research

Therapeutic Target Identified for Small Cell Bladder Cancer

Gene expression analysis uncovers clues

January 30, 2019/Cancer/Research

Survival Rates Higher for Patients with Metastatic Renal Cancer at High-Volume Facilities

Study first to compare rates for mRCC medical oncology

January 28, 2019/Cancer/Research

New Treatment Regimen Holds Promise for Patients with Mantle Cell Lymphoma

Novel drugs included in therapy

January 21, 2019/Basic & Translational Science

Gene Profile Test Holds Predictive Potential for Early Stage Melanoma Patients

Test helpful for SLN-negative, stage I to IIA and thin tumors

January 15, 2019/Cancer/Research

New Chemotherapy Regimen Proves Effective in Treating Amyloidosis

Refractory patients respond to combination therapy

January 10, 2019/Cancer/Research

Efficacy of a First-in-Class SMARCA5/CHD4 Inhibitor in Cell-Based Assays of Acute Myeloid Leukemia

First agent in a new class of noncytotoxic cancer drugs

BackPage 18 of 31Next